Regent Pacific Group Limited (RPGLF)

OTCMKTS · Delayed Price · Currency is USD

0.0059

-0.1191 (-95.28%)

At close: Mar 18, 2026

Market Cap	31.45M +15.0%
Revenue (ttm)	5.40M +548.4%
Net Income	-1.95M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175
Open	0.0059
Previous Close	0.1250
Day's Range	0.0059 - 0.0059
52-Week Range	0.0007 - 0.4333
Beta	1.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholo... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1991

Employees 15

Stock Exchange OTCMKTS

Ticker Symbol RPGLF

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial Statements